Resources / NITAG documentation

Updated guidance to protect infants and children from respiratory syncytial virus (RSV) disease: use of monoclonal antibodies (nirsevimab and clesrovimab) and the RSVpreF vaccine

Download:

Abstract

NACI updated their guidance for use of monoclonal antibodies (nirsevimab and clesrovimab) and the RSVpreF vaccine for infants and children.

  • Americas
  • Canada
  • children
  • infants
  • RSV (Respiratory syncytial virus)
Loading...